학술논문

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
Document Type
Article
Source
In Annals of Oncology July 2016 27(7):1241-1248
Subject
Language
ISSN
0923-7534